CompletedNot Applicable

Hypomagnesemia Associated With Proton-Pump Inhibitor Use

Singapore211,672 participantsStarted 2017-01-31

Plain-language summary

Use of proton pump inhibitors has been associated with hypomagnesemia. However, various case-control or prospective studies have found conflicting results with regards to proton pump inhibitors use and development of hypomagnesemia. Our aim was to evaluate the likelihood that proton pump inhibitors contributed to severe hypomagnesemia in a retrospective cohort of patients admitted with severe hypomagenesemia. We also aimed to look for risk factors leading to development of hypomagnesemia amongst users of proton pump inhibitors

Who can participate

Age range14 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients admitted with hypomagnesemia (cases) * Patients prescribed with proton pump inhibitors (controls) Exclusion Criteria: * Patients prescribed with less than three months duration of proton pump inhibitors (controls)

What they're measuring

Hypomagnesemia due to use with proton pump inhibitor

Timeframe: 2013 to 2016

Trial details

NCT IDNCT04426994

SponsorChangi General Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-01-30

View on ClinicalTrials.gov More Proton Pump Inhibitor Adverse Reaction trials